Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA Issues Class I Recall of Infusion Set Needles - Medical Product Outsourcing

FDA Issues Class I Recall of Infusion Set Needles

Products are manufactured by Nipro Medical Corp. in Japan.

The U.S. Food and Drug Administration (FDA) has issued a Class I recall for Exel/Exelint Huber needles, Exel/Exelint Huber Infusion Sets and Exel/Exelient Securetough+ Safety Huber Infusion Sets, manufactured by Nipro Medical Corp., the agency said.

Huber needles are used to access ports implanted under the skin of chronically ill patients for repeated access to veins for the withdrawal of blood and infusion of medication, nutritional solutions, blood products, and imaging solutions, according to the FDA.

Inspections conducted in October 2009 of Nipro facilities in Japan found that their needles “cored” in 60 to 72 percent of tests. The reason for this coring, the agency said, is related to design and manufacturing processes,

There are more than 2 million units impacted by this recall in distribution nationwide. Recalled needles were manufactured from January 2007 to August 2009.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters